Heart Failure :: Cardiovascular protective benefits of carvedilol in heart failure patients
Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.
logo - spiritindia - Heart Failure :: Cardiovascular protective benefits of carvedilol in heart failure patients

Cardiovascular protective benefits of carvedilol in heart failure patients

Heart Failure :: Cardiovascular protective benefits of carvedilol in heart failure patients

Heart Failure :: Cardiovascular protective benefits of carvedilol in heart failure patients

Patients with heart failure who received the heart medication carvedilol suffered fewer heart attacks and strokes and were less likely to die of these and other vascular events than patients prescribed another beta blocker, metoprolol tartrate, according to a retrospective analysis of COMET (the Carvedilol or Metoprolol European Trial) published in the March 6th issue of The Journal of the American College of Cardiology.

Study investigators looked at whether the effects on vascular events contributed to the beneficial effect of carvedilol in the COMET trial, the longest and largest mortality trial comparing beta-blockers in heart failure patients.

Among its key findings, the analysis documented that carvedilol reduced the risk of heart attacks, unstable angina, or stroke by 19% (p = 0.017). During the study, 106 of the 160 patients on metoprolol tartrate who had a nonfatal heart attack or stroke later died, while 61 of 124 patients on carvedilol who had a nonfatal heart attack or stroke later died.

COMET was a double-blind, randomized parallel group study designed to compare the effects of carvedilol with those of metoprolol tartrate on the risk of death and hospitalizations in patients with congestive heart failure. The study included more than 3,000 patients with heart failure primarily due to ischemic or dilated cardiomyopathy. Study participants were followed for an average of 58 months. According to COMET investigators, the study results suggested that the use of carvedilol in patients with heart failure extended median survival by 1.4 years.




(Heart Failure :: Cardiovascular protective benefits of carvedilol in heart failure patients published at SpiritIndia on Tuesday, March 13, 2007)



Heart Failure

Search more information on Heart Failure, Heart Failure books

Recently posted related articles on Heart Failure :

  1. Heart Failure :: Men with chronic heart failure can have active sex lives
  2. Heart Failure :: ICDs underused in women, minorities with heart failure
  3. Heart Failure :: Drug used for treatment for heart failure in adults may not be beneficial for children and teens
  4. Leukemia :: Heart failure is rare among leukemia patients on imatinib
  5. Heart Failure :: Rasilez, direct renin inhibitor, reduces a marker of heart failure severity
  6. Diabetes :: Boxed warning on heart failure risk on diabetes drug label, says FDA
  7. Heart Failure :: High blood pressure, low energy may cause heart failure
  8. Heart Failure :: Novel candidate biomarker for heart failure also strongly predicts risk of death
  9. Heart :: Cause and treatment of pediatric heart failure
  10. Diabetes :: GlaxoSmithKline statement in diabetes care study thiazolidinediones and heart failure

Most related articles:

- Heart Failure :: Cardiovascular protective benefits of carvedilol in heart failure patients
- Heart Failure :: Drug used for treatment for heart failure in adults may not be beneficial for children and teens - 20
- Heart Failure :: Increases in fasting glucose raised the risk of congestive heart failure - 13.7
- Diabetes :: Diabetes triples risk of heart failure for women - 13.3
- Heart Failure :: Obese patients fair better than lean patients when hospitalized for acute heart failure - 13.2
- Heart Failure :: Research uncovers the significant benefits of remote monitoring - 12.7
- Heart Failure :: Phone monitoring helps patients with chronic heart failure - 12.7
- Heart Failure :: Healthy heart study - living with chronic heart failure - 12.6
- Diabetes :: Diabetes and Heart Failure Is Double Trouble for Older Women - 12.5
- Heart Failure :: Event to benefit heart failure and transplant patients - 12.1


Heart Failure - recent related articles/news stories:

- Injection NRG1 may reverse heart attack damage
- New CRT therapy prevents heart failure
- Merck's heart failure drug rolofylline failed
- DASH diet reduces women's risk of heart failure
- Swine Flu update for people with heart disease

»»   Heart :: Schering-Plough announces clinical trial results for oral thrombin receptor antagonist
««   Hypertension :: Teva receives U.S. approval for generic Uniretic for hypertension






Tools
Daily calorie need
Homeo tips
Homeo softwares
Associations
NHMC Alumni
IFH
PHS
Vital Informer
Articles & news
Education
Homeo articles
Homeopathy cases
Homeopathic Remedies
You
Authors
Submit article
Your account
Testimonials
About
About us
Advertisers
Advertising
Linking us
Disclaimer
Privacy policy

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com